Racemic N1-norphenserine and its enantiomers: Unpredicted inhibition of human acetyl- and butyrylcholinesterase and β-amyloid precursor protein in vitro

Heterocycles

Volumn 61, Issue , 2003, Pages 529-539

  Yu, Qian Sheng ^a   Luo, Weiming ^a   Holloway, Harold W ^a   Utsuki, Tada ^a   Perry, Tracy Ann ^a   Lahiri, Debomoy K ^b   Greig, Nigel H ^a   Brossi, Arnold ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN; CHOLINESTERASE; N' NORPHENSERINE; OXINDOLE; PHYSOSTIGMINE; SERINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CHOLINESTERASE INHIBITION; ENANTIOMER; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; PROTEIN FUNCTION; PROTEIN SECRETION; RACEMIZATION; SYNTHESIS;

EID: 0345760146     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-03-s15     Document Type: Article

References (34)

1. N.H. Greig, X.F. Pei, T.T. Soncrant, D.K. Ingram, and A. Brossi, Med. Chem. Rev., 1995, 15, 3.
2. N.H. Greig, K. Sambamurti, Q.S. Yu, T. Perry, H.W. Holloway, F. Haberman, A. Brossi, D.K. Ingram, and D. K. Lahiri, In, Butyrylcholinesterase: Its Function and Inhibition, ed. by E. Giacobini, Martin Dunitz Ltd., London, 2003.
3. N.H. Greig, D.K. Lahiri, and K. Sambamurti, International Psychogeriatrics, 2002, 14, Suppl. 1: 77.
4. E. Giacobini, Cholinesterases and Cholinesterase Inhibitors, Martin Dunitz, London, 2000.
5. N.H. Greig, E. De Micheli, H.W. Holloway, Q.S. Yu, T. Utsuki, T. Perry, A. Brossi, D.K. Ingram, J. Deutsch, D.K. Lahiri, and T.T. Soncrant, Acta Neurol Scand, 2000, 102, 74.
6. H. Soreq and H. Zakut, Human Cholinesterases and Anticholinesterases, Academic Press, New York, NY, 1993.
7. A. Brossi and X. F. Pei, In, The Alkaloids, ed. by G.A. Cordell, 1998, 50, 126.
8. Q.S. Yu, X. F. Pei, H.W. Holloway, N.H. Greig, and A. Brossi, J. Med. Chem., 1997, 40, 2895.
9. Q.S. Yu, N.H. Greig, H.W. Holloway, and A. Brossi, J. Med. Chem., 1998, 41, 2371.
10. X.F. Pei, N.H. Greig, J.L. Flippen-Anderson, S. Bi, and A. Brossi, Helv. Chim. Acta., 1994, 77, 1412.
11. Q.S. Yu, J.R. Atack, S.I. Rapoport, and A. Brossi, J. Med. Chem., 1988, 31, 2297.
12. Q.S. Yu, X. Zhu, H.W. Holloway, N. Whitaker, A. Brossi, and N.H. Greig, J. Med. Chem., 2002, 45, 3684.
13. X.F. Pei, N.H. Greig, S. Bi, A. Brossi, and V. Toome, Med. Chem. Res., 1995, 5, 265.
14. M. Brzostowska, X. S. He, N.H. Greig, and A. Brossi, Med. Chem. Res., 1992, 2, 238.
15. K.Y.T. Shaw, T. Utsuki, J.R. Rogers, Q.S. Yu, K. Sambamurti, A. Brossi, Y.W. Ge, D.K. Lahiri, and N.H. Greig, Proc. Natl. Acad. Sc., USA, 2001, 98, 7605.
16. D.K. Lahiri, M.R. Farlow, N. Hintz, T. Utsuki, and N.H. Greig, Acta Neurol Scand, 2000, 102, 60.
17. D.K. Lahiri, N.H. Greig, and M.R. Farlow, Research & Practice in Alzheimer's Disease, 2001, 5, 27.
18. D.K. Lahiri, M.R. Farlow, Y.W. Ge, K. Sambamurti, T. Utsuki, and N.H. Greig, In "Mapping the Progress of Alzheimer's and Parkinson's Disease", ed. by Y. Mizuno, A. Fisher, and I. Hanin, Kluwer Academic/ Plenum Publishers, 2002, pp. 211-216.
19. K. Sambamurti, N.H. Greig, and D.K. Lahiri, NeuroMolecular Medicine, 2002, 1, 1.
20. P. L. Julian and J. J. Pikl, J. Am. Chem. Soc., 1935, 57, 755.
21. B. Schönenberger and A. Brossi, Helv. Chim. Acta, 1986, 69, 1486.
22. Q.S. Yu and A. Brossi, Heterocycles, 1988, 27, 745.
23. Q.S. Yu, C. Liu, M. Brzostowska, L. Chrisey, A. Brossi, N.H. Greig, J.R. Atack, T.T. Soncrant, and H.E. Radunz, Helv. Chim. Acta, 1991, 74, 761.
24. Q.S. Yu, B. Schönenberger, and A. Brossi, Heterocycles, 1987, 26, 1271.
25. X.F. Pei and A. Brossi, US Patent 5,571,929, 1996 (Chem. Abstr., 1996, 125, 143116).
26. X.F. Pei, Q.S. Yu, B. Y. Lu, N.H. Greig, and A. Brossi, Heterocycles, 1996, 42, 229.
27. X.F. Pei and A. Brossi, Heterocycles, 1995, 41, 2823.
28. T.B.K. Lee and G.S.K. Wong, J. Org. Chem., 1991, 56, 872.
29. 3).
30. Q.S. Yu, H.W. Holloway, J. Flippen-Anderson, B. Hoffman, A. Brossi, and N.H. Greig, J. Med. Chem., 2001, 44, 4062.
31. D.K. Lahiri, M.R. Farlow, J.I., Jr. Nurnberger, and N.H. Greig, Annals of the NY Acad. Sci., 1997, 826, 416.
32. D.K. Lahiri, M.R. Farlow, N.H. Greig, and K. Sambamurti, Drug Dev. Res., 2002, 56, 267.
33. K. Sambamurti, J. Hardy, L.M. Refolo, and D.K. Lahiri, Drug Dev. Res., 2002, 56, 211.
34. D.K. Lahiri, M.R. Farlow, K. Sambamurti, N.H. Greig, E. Giacobini, and L.S. Schneider, Current Drug Targets, 2003, 4, 97.